VPE: Use of Videos to Improve Patient Knowledge on Prenatal Genetics

Sponsor
University of South Florida (Other)
Overall Status
Completed
CT.gov ID
NCT03816423
Collaborator
Tampa General Hospital (Other)
106
1
2
11.4
9.3

Study Details

Study Description

Brief Summary

This is a randomized controlled trial of a low income and low health literacy population of pregnant women from a diverse racial and ethnic background to assess the effectiveness of a pre-visit educational video on prenatal genetic screening and testing options.

Condition or Disease Intervention/Treatment Phase
  • Other: video
N/A

Detailed Description

During pregnancy, women are routinely counseled about the risks of their offspring to have a chromosomal abnormality or birth defects. Both prenatal screening and diagnostic testing options to exclude aneuploidy should be offered to all pregnant women early in their pregnancy. A standardized educational video on prenatal screening may enhance a patient's understanding and knowledge of testing and support more informed decisions.

The objective of this study is to evaluate and compare patient knowledge scores on prenatal genetic screening before and after a standard prenatal care visit compared to the addition of a pre-appointment educational video.

Study Design

Study Type:
Interventional
Actual Enrollment :
106 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Primary purpose: assess and compare patient knowledge on prenatal genetic screening before and after a standard prenatal care visit compared to the addition of a pre-appointment educational video. All participants will complete a 15-item questionnaire on prenatal genetic screening options at baseline and after routine prenatal care visit. Participants randomized to the control group, will have a routine prenatal care appoinment, while the intervention group will watch a pre-appointment 4.5 minute educational video entitled "How to decide about prenatal genetic testing".Primary purpose: assess and compare patient knowledge on prenatal genetic screening before and after a standard prenatal care visit compared to the addition of a pre-appointment educational video. All participants will complete a 15-item questionnaire on prenatal genetic screening options at baseline and after routine prenatal care visit. Participants randomized to the control group, will have a routine prenatal care appoinment, while the intervention group will watch a pre-appointment 4.5 minute educational video entitled "How to decide about prenatal genetic testing".
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
The Use of Videos for Informed Consent for Prenatal Genetic Screening: a Randomized Controlled Trial
Actual Study Start Date :
May 30, 2019
Actual Primary Completion Date :
Jan 24, 2020
Actual Study Completion Date :
May 12, 2020

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Traditional counseling

Patients will undergo routine prenatal care visit with clinical practicioner only

Experimental: video group

Participants randomized to the intervention group (video education) will view the prenatal screening video "How to Decide About Prenatal Genetic Testing," followed by a routine prenatal appointment.

Other: video
Participants randomized to the intervention group, will wacth a pre-appointment video, followed by a routine prenatal care visit.

Outcome Measures

Primary Outcome Measures

  1. Knowledge score [same day for both groups]

    Evaluate the participants' baseline and post-visit knowledge scores on prenatal genetic screening for both groups using the "Maternal Serum Screening Knowledge Score Questionnaire" (MSSKQ)

  2. Knowledge score change [same day for both groups]

    Compare the knowledge score change for both groups using the Maternal Serum Screening Knowledge Score Questionnaire" (MSSKQ)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • pregnancy, english or spanish-speaking
Exclusion Criteria:
  • minors <18 years old,

  • 21 completed weeks of gestational age,

  • prior genetic counseling during current pregnancy

  • fetus with known ultrasound abnormality

Contacts and Locations

Locations

Site City State Country Postal Code
1 Genesis Healthpark- TGH Tampa Florida United States 33609

Sponsors and Collaborators

  • University of South Florida
  • Tampa General Hospital

Investigators

  • Principal Investigator: Karla Leavitt, MD, MPH, University of South Florida

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of South Florida
ClinicalTrials.gov Identifier:
NCT03816423
Other Study ID Numbers:
  • 00035994
First Posted:
Jan 25, 2019
Last Update Posted:
May 19, 2020
Last Verified:
Mar 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of South Florida
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 19, 2020